Molecular Partners (MOLN) Revenue & Revenue Breakdown
Molecular Partners Revenue Highlights
Latest Revenue (Y)
$7.04M
Latest Revenue (Q)
$2.74M
Main Geography (Y)
SWITZERLAND
Molecular Partners Revenue by Period
Molecular Partners Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $7.04M | -96.29% |
2022-12-31 | $189.56M | 1931.68% |
2021-12-31 | $9.33M | -0.15% |
2020-12-31 | $9.34M | -54.16% |
2019-12-31 | $20.38M | 96.84% |
2018-12-31 | $10.36M | -48.27% |
2017-12-31 | $20.02M | -13.13% |
2016-12-31 | $23.04M | -20.88% |
2015-12-31 | $29.12M | 9.37% |
2014-12-31 | $26.63M | -17.87% |
2013-12-31 | $32.42M | - |
Molecular Partners Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $2.74M | 165.31% |
2023-12-31 | $1.03M | -59.39% |
2023-09-30 | $2.54M | 512.29% |
2023-06-30 | $415.00K | -86.39% |
2023-03-31 | $3.05M | 13.26% |
2022-12-31 | $2.69M | 15.23% |
2022-09-30 | $2.34M | -80.11% |
2022-06-30 | $11.75M | -93.20% |
2022-03-31 | $172.78M | 9633.97% |
2021-12-31 | $1.77M | -49.67% |
2021-09-30 | $3.53M | 9.77% |
2021-06-30 | $3.21M | 294.23% |
2021-03-31 | $815.00K | -47.25% |
2020-12-31 | $1.54M | 445.94% |
2020-09-30 | $283.00K | -87.89% |
2020-06-30 | $2.34M | - |
2020-03-31 | $2.34M | -54.16% |
2019-12-31 | $5.10M | - |
2019-09-30 | $5.10M | - |
2019-06-30 | $5.10M | - |
2019-03-31 | $5.10M | 96.84% |
2018-12-31 | $2.59M | - |
2018-09-30 | $2.59M | - |
2018-06-30 | $2.59M | - |
2018-03-31 | $2.59M | -48.27% |
2017-12-31 | $5.00M | - |
2017-09-30 | $5.00M | - |
2017-06-30 | $5.00M | - |
2017-03-31 | $5.00M | -13.13% |
2016-12-31 | $5.76M | - |
2016-09-30 | $5.76M | - |
2016-06-30 | $5.76M | - |
2016-03-31 | $5.76M | -20.88% |
2015-12-31 | $7.28M | - |
2015-09-30 | $7.28M | - |
2015-06-30 | $7.28M | - |
2015-03-31 | $7.28M | 9.37% |
2014-12-31 | $6.66M | - |
2014-09-30 | $6.66M | - |
2014-06-30 | $6.66M | - |
2014-03-31 | $6.66M | -17.87% |
2013-12-31 | $8.10M | - |
2013-09-30 | $8.10M | - |
2013-06-30 | $8.10M | - |
2013-03-31 | $8.10M | - |
Molecular Partners Revenue Breakdown
Molecular Partners Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 23 | Dec 22 | Dec 21 |
---|---|---|---|
SWITZERLAND | $7.04M | $179.90M | - |
UNITED STATES | - | $9.65M | $9.33M |
Molecular Partners Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
TRDA | Entrada Therapeutics | $129.01M | $94.69M |
MOLN | Molecular Partners | $7.04M | $2.74M |
HCWB | HCW Biologics | $2.84M | $618.85K |
MNOV | MediciNova | $1.00M | - |
OPT | Opthea | $108.41K | $61.27K |
ANEB | Anebulo Pharmaceuticals | - | - |
RZLT | Rezolute | - | - |
ANTX | AN2 Therapeutics | - | - |
PHVS | Pharvaris | - | - |
RLYB | Rallybio | - | $299.00K |
CYT | Cyteir Therapeutics | - | - |
ELYM | Eliem Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
MLYS | Mineralys Therapeutics | - | - |
VIGL | Vigil Neuroscience | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
EWTX | Edgewise Therapeutics | - | - |
PEPG | PepGen | - | - |
CSBR | Champions Oncology | - | - |
MOLN Revenue FAQ
What is Molecular Partners’s yearly revenue?
Molecular Partners's yearly revenue for 2023 was $7.04M, representing a decrease of -96.29% compared to 2022. The company's yearly revenue for 2022 was $189.56M, representing an increase of 1931.68% compared to 2021. MOLN's yearly revenue for 2021 was $9.33M, representing a decrease of -0.15% compared to 2020.
What is Molecular Partners’s quarterly revenue?
Molecular Partners's quarterly revenue for Q1 2024 was $2.74M, a 165.31% increase from the previous quarter (Q4 2023), and a -10.23% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $1.03M, a -59.39% decrease from the previous quarter (Q3 2023), and a -61.68% decrease year-over-year (Q4 2022). MOLN's quarterly revenue for Q3 2023 was $2.54M, a 512.29% increase from the previous quarter (Q2 2023), and a 8.73% increase year-over-year (Q3 2022).
What is Molecular Partners’s revenue growth rate?
Molecular Partners's revenue growth rate for the last 3 years (2021-2023) was -24.57%, and for the last 5 years (2019-2023) was -65.47%.